½ÃÀ庸°í¼­
»óǰÄÚµå
1602076

Àº â»ó ÇǺ¹Àç ½ÃÀå : Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Silver Wound Dressing Market by Product (Advanced, Traditional), End-use (Clinics, Home Healthcare, Hospitals) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 184 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Àº â»ó ÇǺ¹Àç ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 27¾ï 5,000¸¸ ´Þ·¯·Î, 2024³â¿¡´Â 31¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 14.24%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 70¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Àº â»ó ÇǺ¹ÀçÀº Ç×±Õ Æ¯¼ºÀ¸·Î ¾Ë·ÁÁø ÀºÀ» ÁÖÀÔÇÑ Æ¯¼ö ÀÇ·á¿ë µå·¹½ÌÀ¸·Î »óó °ü¸® ¹× °¨¿° ¿¹¹æÀ» À§ÇØ ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ µå·¹½Ì Àç·áÀÇ Çʿ伺Àº ƯÈ÷ Ç×»ýÁ¦ ³»¼º ¹ÚÅ׸®¾Æ Áõ°¡¿¡ Á÷¸éÇÏ¿© ¸¸¼º ¹× ±Þ¼º »óó¸¦ È¿À²ÀûÀ¸·Î °ü¸®ÇØ¾ß ÇÒ Çʿ伺¿¡¼­ ºñ·ÔµÇ¾ú½À´Ï´Ù. ±× ¿ëµµ´Â È­»ó, ¼ö¼ú »óó, ±Ë¾ç, ´ç´¢º´¼º Á·ºÎ ±Ë¾ç µî ´Ù¾çÇÑ »óó À¯Çü¿¡ Àû¿ëµË´Ï´Ù. ÃÖÁ¾ ¿ëµµ´Â º´¿ø, Áø·á¼Ò, ÀçÅà ¿ä¾ç ȯ°æ, Àå±â ¿ä¾ç ½Ã¼³ µî¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023] 27¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â[2024] 31¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â[2030] 70¾ï ´Þ·¯
CAGR(%) 14.24%

Àº â»ó ÇǺ¹Àç ½ÃÀåÀº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ È®»ê, Àα¸ °í·ÉÈ­, Àü ¼¼°è ¼ö¼ú °Ç¼ö Áõ°¡´Â È¿°úÀûÀÎ »óó °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ã·´Ü »óó °ü¸® Á¦Ç°¿¡ ´ëÇÑ Àνİú ÀÌÇØµµ°¡ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Àº µå·¹½Ì Àç·á´Â ±âÁ¸ÀÇ ´ë¾È¿¡ ºñÇØ °í°¡¶ó´Â Á¡°ú ¾ËÁú¸®¾Æ(Àº °ú´Ù »ç¿ëÀ¸·Î ÀÎÇÑ ºÎÀÛ¿ë)¿Í °°Àº ÀáÀçÀû ºÎÀÛ¿ëÀÌ ÀÖ´Ù´Â Á¡ÀÌ Á¦¾àÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±ÔÁ¦ À庮°ú »óȯ ¹®Á¦°¡ ½ÃÀå È®´ë¸¦ ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

ºñ¿ë È¿À²ÀûÀÎ Àº µå·¹½Ì Àç·áÀÇ °³¹ß, Àº°ú ´Ù¸¥ Ç×±ÕÁ¦¸¦ °áÇÕÇÏ¿© È¿°ú¸¦ ³ôÀÌ´Â µî Á¦Ç° ó¹æÀÇ Çõ½Å¿¡ ÀáÀçÀûÀÎ ±âȸ°¡ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ÀÎÇÁ¶ó°¡ Àß °®Ãß¾îÁø ½ÅÈï ½ÃÀåÀ¸·ÎÀÇ ÁøÃâµµ Å« ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À±â¼úÀÇ ¹ßÀüÀ¸·Î »ýüÀûÇÕ¼ºÀÌ ³ô°í ȯ°æ ģȭÀûÀÎ Á¦Ç°ÀÌ °³¹ßµÈ´Ù¸é ´õ Å« ¼ºÀåÀÇ ±æÀ» ¿­ ¼ö ÀÖÀ» °ÍÀÔ´Ï´Ù.

ÀºÀÇ À¯ÀÍÇÑ Ç×±Õ¼º°ú °Ç°­ÇÑ ¼¼Æ÷¿¡ ´ëÇÑ ¼¼Æ÷ µ¶¼º ÀÛ¿ëÀ» ÃÖ¼ÒÈ­ÇÏ´Â °Í »çÀÌÀÇ ±ÕÇüÀ» À¯ÁöÇÏ´Â °ÍÀÌ °úÁ¦ÀÔ´Ï´Ù. ¶ÇÇÑ ÇÏÀ̵å·ÎÄÝ·ÎÀÌµå ¹× ¾Ë±ä»ê µå·¹½Ì°ú °°Àº ´ëü ÷´Ü »óó °ü¸® Á¦Ç°°úÀÇ °æÀïµµ ½ÃÀå ÁøÀÔ¿¡ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

Àº ³ª³ëÀÔÀÚ¸¦ µå·¹½Ì Àç·á¿¡ ³»ÀåÇÏ´Â ³ª³ëÅ×Å©³î·¯ÁöÀÇ Çõ½ÅÀº À¯¸ÁÇÑ ¿¬±¸ °æ·Î¸¦ º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ ÇൿÀ» ÀÌÇØÇϰí, ȯ°æ ģȭÀûÀÎ ¹æ¹ýÀ» ¿ì¼±½ÃÇϰí, ´Ù±â´É Ư¼ºÀ» °¡Áø µå·¹½Ì Àç·á¸¦ °³¹ßÇÏ´Â °Íµµ °æÀï·ÂÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀ̸ç Áö¼ÓÀûÀÎ ¼ºÀåÀ» À§Çؼ­´Â »óó Ä¡·á ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀÌ ÇʼöÀûÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Àº â»ó ÇǺ¹Àç ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Àº â»ó ÇǺ¹Àç ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º ¹× ±Þ¼º »óó ȯÀÚ Áõ°¡
    • Àü ¼¼°è ±³Åë»ç°í ¹× ºÎ»óÀÚ ¼ö Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Àº â»ó ÇǺ¹Àç Àç·á ¹× Á¦Ç° ¸®ÄÝ¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ±âȸ
    • ÷´Ü Àº »óó Ä¡·á¿¡ ´ëÇÑ ÀǽÄÀÇ Çâ»ó ¹× ¼Ò°³
    • ÁøÈ­ÇÏ´Â ´Ù±â´É ½Ç¹ö »óó µå·¹½Ì Àç·á
  • ½ÃÀå °úÁ¦
    • ´ëü »óó µå·¹½Ì Àç·á »ç¿ë

Portre's Five Forces: Àº â»ó ÇǺ¹Àç ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû Åø

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Àº â»ó ÇǺ¹Àç ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Àº â»ó ÇǺ¹Àç ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼®Àº â»ó ÇǺ¹ÀçÀç ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

Àº â»ó ÇǺ¹Àç ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ½Ç¹ö »óó µå·¹½Ì ½ÃÀå¿¡¼­ÀÇ º¥´õÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Àº â»ó ÇǺ¹Àç ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀº º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ±¸ºÐÇÏ¿© »ç¿ëÀÚ°¡ Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. :

1. ½ÃÀå ħÅõµµ : ¾÷°è ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅ͸¦ Æ÷ÇÔÇÑ ÇöÀç ½ÃÀå ȯ°æ¿¡ ´ëÇÑ »ó¼¼ÇÑ °ËÅä.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù. :

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Àº â»ó ÇǺ¹Àç ½ÃÀå : Á¦Ç°º°

  • ÷´ÜÇü
    • ³ª³ë°áÁ¤ Àºµå·¹½Ì
    • ¾Ë±ä»êÀº
    • ½Ç¹ö Æû µå·¹½Ì
    • ÀºÇÏÀ̵å·Î°Ö/ÇÏÀ̵å·ÎÆÄÀ̹ö
    • Àºµµ±Ý ³ªÀÏ·Ð ¼¶À¯ µå·¹½Ì
  • ±âÁ¸
    • ÀººØ´ë
    • Áú»êÀº µå·¹½Ì

Á¦7Àå Àº â»ó ÇǺ¹Àç ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • Ŭ¸®´Ð
  • ÀçÅà ÇコÄɾî
  • º´¿ø

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ Àº â»ó ÇǺ¹Àç ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àº â»ó ÇǺ¹Àç ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àº â»ó ÇǺ¹Àç ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®

±â¾÷ ¸®½ºÆ®

  • Arshine Lifescience Co., Limited
  • Smith & Nephew PLC
  • Statex Produktions-und Vertriebs GmbH
  • Coloplast A/S
  • Medline Industries, LP
  • Argentum Medical, LLC
  • McKesson Corporation
  • Winner Medical Co., Ltd.
  • Strive Medical, LLC
  • Milliken & Company
  • ConvaTec Group PLC
  • Hartmann Group
  • Johnson & Johnson Services, Inc.
  • Exciton Technologies Inc.
  • B. Braun SE
  • Ferris Mfg. Corp.
  • DermaRite Industries, LLC
  • Hollister Incorporated
  • Dynarex Corporation
  • Cardinal Health, Inc.
  • Integra LifeSciences Holdings Corporation
  • Molnlycke Health Care AB
  • Urgo Medical North America by SteadMed Medical, LLC
  • Covalon Technologies Ltd.
  • 3M Company
KSA 24.12.10

The Silver Wound Dressing Market was valued at USD 2.75 billion in 2023, expected to reach USD 3.14 billion in 2024, and is projected to grow at a CAGR of 14.24%, to USD 7.00 billion by 2030.

Silver wound dressings are specialized medical dressings infused with silver, known for its antimicrobial properties, designed for managing and preventing infections in wounds. The necessity of these dressings arises from the need to manage chronic and acute wounds efficiently, especially in the face of increasing antibiotic-resistant bacteria. Their application spans various wound types, including burns, surgical wounds, ulcers, and diabetic foot ulcers. In terms of end-use, hospitals, clinics, home care settings, and long-term care facilities widely utilize these products.

KEY MARKET STATISTICS
Base Year [2023] USD 2.75 billion
Estimated Year [2024] USD 3.14 billion
Forecast Year [2030] USD 7.00 billion
CAGR (%) 14.24%

The market for silver wound dressings is driven by several key factors. The increasing prevalence of chronic diseases, an aging population, and a rising number of surgical procedures globally heighten the demand for effective wound care solutions. Moreover, the growing awareness and understanding of advanced wound care products are propelling market growth. However, limitations such as the high cost of silver dressings compared to conventional options and potential side effects like argyria (a condition caused by excess silver) pose challenges. In addition, regulatory hurdles and reimbursement issues can stifle market expansion.

Potential opportunities lie in developing cost-effective silver dressings and innovations in product formulations, such as combining silver with other antimicrobial agents for enhanced efficacy. There is also significant potential in expanding into emerging markets where healthcare infrastructure improvements are underway. Advancements in biotechnology in creating more biocompatible and eco-friendly products present additional growth avenues.

Challenges include managing the balance between silver's beneficial antimicrobial properties and minimizing cytotoxic effects on healthy cells. Additionally, competition from alternative advanced wound care products, like hydrocolloid or alginate dressings, presents market hurdles.

Innovation in nanotechnology for embedding silver nanoparticles into dressings offers promising research paths. Understanding consumer behavior, prioritizing eco-friendly practices, and developing dressings with multifunctional properties could also provide a competitive edge. The market is dynamic, with continuous advancements in wound care technology essential for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Silver Wound Dressing Market

The Silver Wound Dressing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Incidence of Chronic and Acute Wounds Among Patients
    • Growing Number of Road Accidents and Injuries Globally
  • Market Restraints
    • Concerns Associated with Silver Wound Dressing and Product Recalls
  • Market Opportunities
    • Emerging Awareness and Introduction of Advanced Silver Wound Care Treatment
    • Evolving Multifunctional Silver Wound Dressings
  • Market Challenges
    • Use of Alternative Wound Dressings

Porter's Five Forces: A Strategic Tool for Navigating the Silver Wound Dressing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Silver Wound Dressing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Silver Wound Dressing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Silver Wound Dressing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Silver Wound Dressing Market

A detailed market share analysis in the Silver Wound Dressing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Silver Wound Dressing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Silver Wound Dressing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Silver Wound Dressing Market, highlighting leading vendors and their innovative profiles. These include Arshine Lifescience Co., Limited, Smith & Nephew PLC, Statex Produktions- und Vertriebs GmbH, Coloplast A/S, Medline Industries, LP, Argentum Medical, LLC, McKesson Corporation, Winner Medical Co., Ltd., Strive Medical, LLC, Milliken & Company, ConvaTec Group PLC, Hartmann Group, Johnson & Johnson Services, Inc., Exciton Technologies Inc., B. Braun SE, Ferris Mfg. Corp., DermaRite Industries, LLC, Hollister Incorporated, Dynarex Corporation, Cardinal Health, Inc., Integra LifeSciences Holdings Corporation, Molnlycke Health Care AB, Urgo Medical North America by SteadMed Medical, LLC, Covalon Technologies Ltd., and 3M Company.

Market Segmentation & Coverage

This research report categorizes the Silver Wound Dressing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Advanced and Traditional. The Advanced is further studied across Nano Crystalline Silver Dressings, Silver Alginates, Silver Foam Dressing, Silver Hydrogel/Hydrofibre, and Silver Plated Nylon Fiber Dressing. The Traditional is further studied across Silver Bandages and Silver Nitrate Dressing.
  • Based on End-use, market is studied across Clinics, Home Healthcare, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Incidence of Chronic and Acute Wounds Among Patients
      • 5.1.1.2. Growing Number of Road Accidents and Injuries Globally
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns Associated with Silver Wound Dressing and Product Recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Awareness and Introduction of Advanced Silver Wound Care Treatment
      • 5.1.3.2. Evolving Multifunctional Silver Wound Dressings
    • 5.1.4. Challenges
      • 5.1.4.1. Use of Alternative Wound Dressings
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significant preference for advanced silver wound dressings to prevent infection and promote faster healing
    • 5.2.2. End-use: Rising usage of highest performance and most versatile dressing options in the hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Silver Wound Dressing Market, by Product

  • 6.1. Introduction
  • 6.2. Advanced
    • 6.2.1. Nano Crystalline Silver Dressings
    • 6.2.2. Silver Alginates
    • 6.2.3. Silver Foam Dressing
    • 6.2.4. Silver Hydrogel/Hydrofibre
    • 6.2.5. Silver Plated Nylon Fiber Dressing
  • 6.3. Traditional
    • 6.3.1. Silver Bandages
    • 6.3.2. Silver Nitrate Dressing

7. Silver Wound Dressing Market, by End-use

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Home Healthcare
  • 7.4. Hospitals

8. Americas Silver Wound Dressing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Silver Wound Dressing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Silver Wound Dressing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Winner Silver Alginate Dressing has Obtained 510K Code in the USA
    • 11.3.2. Argentum Medical acquires Anacapa Technologies

Companies Mentioned

  • 1. Arshine Lifescience Co., Limited
  • 2. Smith & Nephew PLC
  • 3. Statex Produktions- und Vertriebs GmbH
  • 4. Coloplast A/S
  • 5. Medline Industries, LP
  • 6. Argentum Medical, LLC
  • 7. McKesson Corporation
  • 8. Winner Medical Co., Ltd.
  • 9. Strive Medical, LLC
  • 10. Milliken & Company
  • 11. ConvaTec Group PLC
  • 12. Hartmann Group
  • 13. Johnson & Johnson Services, Inc.
  • 14. Exciton Technologies Inc.
  • 15. B. Braun SE
  • 16. Ferris Mfg. Corp.
  • 17. DermaRite Industries, LLC
  • 18. Hollister Incorporated
  • 19. Dynarex Corporation
  • 20. Cardinal Health, Inc.
  • 21. Integra LifeSciences Holdings Corporation
  • 22. Molnlycke Health Care AB
  • 23. Urgo Medical North America by SteadMed Medical, LLC
  • 24. Covalon Technologies Ltd.
  • 25. 3M Company
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦